<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21301" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Erythema Nodosum</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hafsi</surname>
            <given-names>Wissem</given-names>
          </name>
          <aff>Faculty of Medicine of Tunis, Tunisia</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Badri</surname>
            <given-names>Talel</given-names>
          </name>
          <aff>University of Tunis El Manar</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Wissem Hafsi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Talel Badri declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>28</day>
          <month>11</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21301.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Erythema nodosum (EN) is a common acute nodular septal panniculitis, characterized by the sudden onset of erythematous, firm, solid, deep nodules or plaques that are painful on palpation and mainly localized on extensor surfaces of the legs. This activity reviews the causes, pathophysiology, and presentation of erythema nodosum and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Recall the cause of erythema nodosum.</p></list-item><list-item><p>Describe the presentation of erythema nodosum.</p></list-item><list-item><p>Summarize the treatment for erythema nodosum.</p></list-item><list-item><p>Review the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by erythema nodosum.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21301&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21301">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21301.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Erythema nodosum (EN) is a common acute nodular septal panniculitis, characterized by the sudden onset of erythematous, firm, solid, deep nodules or plaques painful on palpation and mainly localized on extensor surfaces of the legs.&#x000a0;These nodules are characterized by a typical histological appearance regardless of the etiology, marked by acute inflammation of the dermo-hypodermic junction and interlobular septa of the hypodermic fat, evolving without necrosis or sequelae.<xref ref-type="bibr" rid="article-21301.r1">[1]</xref><xref ref-type="bibr" rid="article-21301.r2">[2]</xref><xref ref-type="bibr" rid="article-21301.r3">[3]</xref></p>
        <p>Erythema nodosum is an acute or recurrent hypersensitivity reaction to a variety of antigens with a clear female predominance that may be associated with several different stimuli or pathological conditions. See <bold>Images.</bold>&#x000a0;Erythema Nodosum.</p>
      </sec>
      <sec id="article-21301.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Erythema nodosum can occur due to a vast number of underlying causes including but not limited to idiopathic, infectious, and a variety of noninfectious causes as outlined below.<xref ref-type="bibr" rid="article-21301.r4">[4]</xref><xref ref-type="bibr" rid="article-21301.r5">[5]</xref><xref ref-type="bibr" rid="article-21301.r6">[6]</xref><xref ref-type="bibr" rid="article-21301.r7">[7]</xref></p>
        <p>Idiopathic: No obvious etiology&#x000a0;have&#x000a0;been found in about 30% to 50% of published cases</p>
        <p>
<bold>Infections</bold>
</p>
        <p>Bacterial</p>
        <list list-type="bullet">
          <list-item>
            <p>Streptococcal infections-most common infectious etiology commonly streptococcal pharyngitis (28 to 48%)</p>
          </list-item>
          <list-item>
            <p>Tuberculosis</p>
          </list-item>
          <list-item>
            <p>Leprosy</p>
          </list-item>
          <list-item>
            <p>Yersinia species&#x000a0;(in Europe), salmonella, campylobacter gastroenteritis</p>
          </list-item>
          <list-item>
            <p>Mycoplasma pneumonia</p>
          </list-item>
          <list-item>
            <p>Tularemia</p>
          </list-item>
          <list-item>
            <p>Cat scratch disease&#x000a0;(Bartonella species)</p>
          </list-item>
          <list-item>
            <p>Leptospirosis</p>
          </list-item>
          <list-item>
            <p>Brucellosis</p>
          </list-item>
          <list-item>
            <p>Psittacosis</p>
          </list-item>
          <list-item>
            <p>Chlamydia trachomatous</p>
          </list-item>
          <list-item>
            <p>Lymphogranuloma venereum</p>
          </list-item>
        </list>
        <p>Viral</p>
        <list list-type="bullet">
          <list-item>
            <p>Infectious mononucleosis</p>
          </list-item>
          <list-item>
            <p>Hepatitis B, Hepatitis C</p>
          </list-item>
          <list-item>
            <p>Human immunodeficiency virus (HIV)</p>
          </list-item>
          <list-item>
            <p>Herpes simplex virus (HSV)</p>
          </list-item>
          <list-item>
            <p>Epstein-Barr virus (EBV)</p>
          </list-item>
          <list-item>
            <p>Para vaccinia</p>
          </list-item>
        </list>
        <p>Fungal</p>
        <list list-type="bullet">
          <list-item>
            <p>Coccidioidomycosis</p>
          </list-item>
          <list-item>
            <p>Histoplasmosis</p>
          </list-item>
          <list-item>
            <p>Blastomycosis</p>
          </list-item>
        </list>
        <p>Parasitic</p>
        <list list-type="bullet">
          <list-item>
            <p>Amebiasis</p>
          </list-item>
          <list-item>
            <p>Giardiasis</p>
          </list-item>
        </list>
        <p>
<bold>Noninfectious Causes</bold>
</p>
        <p>Drugs</p>
        <list list-type="bullet">
          <list-item>
            <p>Antibiotics- penicillins, sulfonamides</p>
          </list-item>
          <list-item>
            <p>Miscellaneous drugs- Oral contraceptives, bromides, iodides, TNF-alpha inhibitor</p>
          </list-item>
        </list>
        <p>Malignancy</p>
        <list list-type="bullet">
          <list-item>
            <p>Leukemia</p>
          </list-item>
          <list-item>
            <p>Lymphoma</p>
          </list-item>
          <list-item>
            <p>Occult malignancies</p>
          </list-item>
        </list>
        <p>Inflammatory Bowel Disease</p>
        <list list-type="bullet">
          <list-item>
            <p>Crohn disease</p>
          </list-item>
          <list-item>
            <p>Ulcerative colitis</p>
          </list-item>
        </list>
        <p>Miscellaneous</p>
        <list list-type="bullet">
          <list-item>
            <p>Sarcoidosis-Lofgren syndrome (a triad of erythema nodosum, acute arthritis, and hilar lymphadenopathy)</p>
          </list-item>
          <list-item>
            <p>Pregnancy</p>
          </list-item>
          <list-item>
            <p>Whipple disease</p>
          </list-item>
          <list-item>
            <p>Behcet disease</p>
          </list-item>
        </list>
        <p>Some pregnant patients may develop erythema nodosum during the second trimester. In addition, recurrence of the disorder may also occur with future pregnancies.</p>
      </sec>
      <sec id="article-21301.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>EN is the most common clinical form of acute nodular hypodermis. &#x000a0;It occurs more often in women between 25 and 40 years but can be observed at any age. Compared to men, women are affected three to six times more. It is rare without sex predominance in the pediatric population.&#x000a0;Of worldwide ubiquitous distribution, there is, however,&#x000a0;an ethnic and geographical difference in the incidences explained by the variation of triggering etiological factors.&#x000a0;Familial cases have been reported and are usually caused by an infectious etiology.</p>
      </sec>
      <sec id="article-21301.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>EN is the result of a nonspecific cutaneous reaction to various antigens. The mechanism involved would be immunologically mediated. Numerous direct and indirect evidence supports the notion of type IV delayed hypersensitivity response to many antigens. It&#x000a0;is postulated that the pathogenesis may be due to the deposition of immune complexes in the venules of subcutaneous fat, the production of oxygen free radicals, TNF-alpha, and granuloma formation. However, this hypothesis is not accepted by all authors.</p>
      </sec>
      <sec id="article-21301.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Skin biopsy is not usually needed in the typical forms as a diagnosis can be reached from a detailed history and physical examination. Usual features suggestive of EN include acute onset tender nodules on typical locations(most commonly on shins).</p>
        <p>Skin biopsy is useless in typical forms. It is indicated in cases of unusual topography, the persistence of nodules several weeks, fistulization or atrophic scarring, and/or livedoid disposition of nodules. It highlights the involvement of interlobular septa by a lymphohistiocytic inflammatory infiltrate, sparing fat lobules and vessels. This aspect is invariable, whatever the etiology.</p>
      </sec>
      <sec id="article-21301.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>EN is characterized in a rather stereotyped way, whatever its cause, by the following evolutionary aspects:</p>
        <p>
<bold>Prodromal Phase</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Nonspecific from 3 to 6 days</p>
          </list-item>
          <list-item>
            <p>Marked by fever, joint, and sometimes abdominal pain.</p>
          </list-item>
          <list-item>
            <p>Often a picture of infection nasopharyngeal, with a slight alteration of the general condition.</p>
          </list-item>
        </list>
        <p>
<bold>Stade Phase</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Settles quickly in 1 to 2 days.</p>
          </list-item>
          <list-item>
            <p>The general syndrome occurs with fever, and arthralgia of the prodromal phase persists or increases.</p>
          </list-item>
          <list-item>
            <p>Nodules appear on the extensor surfaces of the legs and knees, and sometimes thighs and forearms.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Nodules are small, 3 to 6, sometimes more, bilateral, roughly symmetrical, and spontaneously painful.</p>
          </list-item>
          <list-item>
            <p>The clinical examination allows specifying the characters of the knots: 10 to 40 mm diameter; warm and firm on palpation, which accentuates their painful character; mobile in relation to the deep planes.</p>
          </list-item>
          <list-item>
            <p>The pain of the lesions is exacerbated by orthostatism, which leads the patient to seek the lying position with raised legs spontaneously.</p>
          </list-item>
          <list-item>
            <p>Edema of the ankles is often present.</p>
          </list-item>
          <list-item>
            <p>Hilar adenopathy may also occur and be confused with sarcoidosis</p>
          </list-item>
        </list>
        <p>
<bold>Regressive Phase</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Evolution is spontaneous but may be accelerated by rest or treatment symptomatic.</p>
          </list-item>
          <list-item>
            <p>Each nodule evolves in ten days, taking blue and yellowish contusiform aspects towards complete disappearance without sequelae.</p>
          </list-item>
        </list>
        <p>EN&#x000a0;never involves necrosis, ulceration, or scarring. It often evolves in several outbreaks, favored by orthostatism and spreading out, at worst, over 4 to 8 weeks. The succession of outbreaks confers on the eruption of a polymorphic appearance with knots of different ages, featuring the various shades of local biligenia.</p>
        <p>Besides the skin lesion, more than 50% of patients will also complain of joint and muscle pain. Sometimes joint swelling and morning stiffness may be present. The swelling may resolve in a few days, but the pain may last for a few months. There is usually no joint destruction, and the synovial fluid is sterile.</p>
      </sec>
      <sec id="article-21301.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The positive diagnosis of EN is primarily clinical. However, a thorough anamnesis (looking for tuberculous contagion, fever, bloody diarrhea, abdominal pain, respiratory problems, dysphagia, etc.) should be conducted as well as a complete clinical examination, always looking for associated signs.</p>
        <p>In typical cases, a complementary investigation for positive diagnosis is not necessary. Nevertheless, it finds its place in the etiological diagnosis. Taking into account the above, the etiological assessment of an EN should include examinations according to the clinical orientation.</p>
        <list list-type="bullet">
          <list-item>
            <p>Blood count, vital signs, and C-reactive protein (in case of infectious context)</p>
          </list-item>
          <list-item>
            <p>Mantoux + chest x-ray + interferon-gamma blood test (in case of tuberculous contagion or suspicion of L&#x000f6;fgren syndrome)</p>
          </list-item>
          <list-item>
            <p>Throat smear + culture + rapid test - serology: anti-streptolysin O and streptodornase (in case of streptococcal suspicion)</p>
          </list-item>
          <list-item>
            <p>Viral serology, two samples at four-week intervals (in case of suspicion of virosis)</p>
          </list-item>
          <list-item>
            <p>Stool and stool examination (in case of diarrhea or digestive symptoms)</p>
          </list-item>
          <list-item>
            <p>Cutaneous biopsy in atypical cases or in case of doubt</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21301.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Extended rest is desirable and may require work stoppage. Analgesics are prescribed on request. Venous compression reduces the pain felt in orthostatism. Steroidal anti-inflammatory drugs, colchicine (1 to 2 mg/day), may be prescribed until symptoms improve. Etiologic treatment is essential in some cases, and antibiotic therapy is needed in case of streptococcal infection or anti-tuberculosis treatment. In the case of L&#x000f6;fgren syndrome, pulmonary radiographic monitoring is recommended because if mediastinal adenopathies disappear in a few months in most patients, sarcoidosis may persist in 10% of cases.<xref ref-type="bibr" rid="article-21301.r8">[8]</xref><xref ref-type="bibr" rid="article-21301.r9">[9]</xref></p>
      </sec>
      <sec id="article-21301.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Non-suppurative infectious dermo hypodermitis diagnosis</p>
          </list-item>
          <list-item>
            <p>Nodular hypodermitis with vascular involvement (periarteritis nodosa and superficial thrombophlebitis) and damage to deep vessels of medium to sometimes large diameter is associated with hypodermic septal or lobular involvement. Nodules can become necrotic. The diagnosis is primarily histological.</p>
          </list-item>
          <list-item>
            <p>Lobular hypodermitis or panniculitis involves lesions that are primarily greasy. The diagnosis is primarily histological, hence the absolute need for biopsy. Several entities have been distinguished. The nodules can liquefy, fistulate, and leave a scar.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21301.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis for patients with EN is good but there is a small risk of recurrence. The skin lesions often take months to resolve but there is usually no scarring or pigmentation change.</p>
      </sec>
      <sec id="article-21301.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>EN is a benign syndrome with a spontaneously favorable course, which is related to an underlying condition that needs to be diagnosed by clinical examination and some complementary oriented tests. In addition to symptomatic treatment, that of the underlying condition may be necessary.</p>
      </sec>
      <sec id="article-21301.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>EN is often encountered by primary care providers and nurse practitioners. While the diagnosis is clinical in most cases, sometimes a biopsy may be required to rule out another disorder. Healthcare workers should seek a consult with a dermatologist or rheumatologist if there is any doubt about the diagnosis. For the most part, the treatment is conservative with rest. Primary care clinicians should not initiate any type of medical therapy if the diagnosis is uncertain. In addition, since the diagnosis is clinical, the patient should not be subjected to unnecessary procedures.&#x000a0; The type of laboratory workup depends on the suspected cause. While EN may be painful, it is a benign disorder that usually remits spontaneously. If the primary disorder is not managed, EN may persist for months or even years. The pharmacist should ensure that the patient is on no medication that causes EN. If the female is on an oral contraceptive, then an alternative form of contraception should be recommended. The primary care clinicians should communicate with the dermatologist to ensure that the patient is receiving the optimal level of care. [Level 5]</p>
      </sec>
      <sec id="article-21301.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21301&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21301">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/erythema-nodosum/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21301">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21301/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21301">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-21301.s15">
        <fig id="article-21301.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Erythema Nodosum <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="erythema__nodosum" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-21301.s16">
        <fig id="article-21301.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Erythema Nodosum Norman Purvis Walker, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://commons.wikimedia.org/w/index.php?search=Norman+Purvis+Walker&#x00026;title=Special:MediaSearch&#x00026;go=Go&#x00026;type=image">Public Domain</ext-link>,&#x000a0;via Wikimedia Commons</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="469px-An_introduction_to_dermatology_x1905x_ERYTHEMA_NODOSUM" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-21301.s17">
        <fig id="article-21301.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Erythema Nodosum Contributed by&#x000a0;S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="EN" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-21301.s18">
        <fig id="article-21301.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Erythema Nodosum James Heilman, MD, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://commons.wikimedia.org/w/index.php?search=ENlegs&#x00026;title=Special:MediaSearch&#x00026;go=Go&#x00026;type=image">Public Domain</ext-link>, via Wikimedia Commons</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ErythemaNodosum" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-21301.s19">
        <title>References</title>
        <ref id="article-21301.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roth</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Biedermann</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fournier</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Butter</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vavricka</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Navarini</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Rogler</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Scharl</surname>
                <given-names>M</given-names>
              </name>
              <collab>Swiss IBD Cohort Study Group</collab>
            </person-group>
            <article-title>Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.</article-title>
            <source>PLoS One</source>
            <year>2019</year>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>e0210436</fpage>
            <pub-id pub-id-type="pmid">30682031</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21301.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morgado</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Batista</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Coutinho</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cardoso</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Tellechea</surname>
                <given-names>&#x000d3;</given-names>
              </name>
            </person-group>
            <article-title>Erythema nodosum and sarcoid granulomas - letting the cat out of the bag.</article-title>
            <source>Dermatol Online J</source>
            <year>2018</year>
            <month>Dec</month>
            <day>15</day>
            <volume>24</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">30677793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21301.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choi</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Won</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>A case of erythema nodosum-like panniculitis induced by nivolumab in a patient with oesophageal cancer.</article-title>
            <source>Australas J Dermatol</source>
            <year>2019</year>
            <month>May</month>
            <volume>60</volume>
            <issue>2</issue>
            <fpage>154</fpage>
            <page-range>154-156</page-range>
            <pub-id pub-id-type="pmid">30656640</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21301.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fujikawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Senoo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Recurrent Erythema Nodosum as a Warning of Tuberculous Lymphadenitis.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>94</volume>
            <issue>1</issue>
            <fpage>174</fpage>
            <page-range>174-175</page-range>
            <pub-id pub-id-type="pmid">30611448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21301.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Algahtani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shirah</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Marghalani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Algarni</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Erythema nodosum in a patient with multiple sclerosis on dimethyl fumarate.</article-title>
            <source>Mult Scler Relat Disord</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>28</volume>
            <fpage>155</fpage>
            <page-range>155-158</page-range>
            <pub-id pub-id-type="pmid">30597324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21301.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Porges</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shafat</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sagy</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Zeller</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bartal</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Khutarniuk</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jotkowitz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barski</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Clinical, Epidemiological, and Etiological Changes in Erythema Nodosum.</article-title>
            <source>Isr Med Assoc J</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>20</volume>
            <issue>12</issue>
            <fpage>770</fpage>
            <page-range>770-772</page-range>
            <pub-id pub-id-type="pmid">30550008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21301.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanami</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kikuchi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Association of pyoderma gangrenosum, erythema nodosum and aseptic liver abscess without significant underlying disease.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>44</volume>
            <issue>2</issue>
            <fpage>e16</fpage>
            <page-range>e16-e17</page-range>
            <pub-id pub-id-type="pmid">30460715</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21301.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leung</surname>
                <given-names>AKC</given-names>
              </name>
              <name>
                <surname>Leong</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Erythema nodosum.</article-title>
            <source>World J Pediatr</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>548</fpage>
            <page-range>548-554</page-range>
            <pub-id pub-id-type="pmid">30269303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21301.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laroche</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alarcon Chinchilla</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bourgeault</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dor&#x000e9;</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Erythema Nodosum as the Initial Presentation of Nivolumab-Induced Sarcoidosis-Like Reaction.</article-title>
            <source>J Cutan Med Surg</source>
            <year>2018</year>
            <season>Nov/Dec</season>
            <volume>22</volume>
            <issue>6</issue>
            <fpage>627</fpage>
            <page-range>627-629</page-range>
            <pub-id pub-id-type="pmid">29772919</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
